Medindia
Medindia LOGIN REGISTER
Advertisement

Cardiac Science to Present at the UBS Global Life Sciences Conference

Tuesday, September 18, 2007 General News
Advertisement
BOTHELL, Wash., Sept. 17 Cardiac ScienceCorporation (Nasdaq: CSCX), a global leader in advanced cardiac monitoring anddefibrillation products, announced today that it will present at the UBSGlobal Life Sciences Conference at the Grand Hyatt in New York City. TheCompany's presentation is scheduled for Monday, September 24, 2007 at 3:30 p.m.
Advertisement

Eastern Time. Michael Matysik, senior vice president and chief financialofficer, will review the Company's business strategy and recent financialresults.
Advertisement

(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO)

Attendance at the conference is by invitation only. Cardiac Science willoffer a live audio webcast of its presentation, which may be accessed at theCompany's website at http://www.cardiacscience.com. An archived replay of thepresentation will also be available following the live presentation and can beaccessed at http://www.cardiacscience.com.

About Cardiac Science Corporation

Cardiac Science is truly at the heart of saving lives. The Companydevelops, manufactures, and markets a family of advanced diagnostic andtherapeutic cardiology devices and systems, including AEDs,electrocardiographs, stress test systems, Holter monitoring systems, hospitaldefibrillators, cardiac rehabilitation telemetry systems, patientmonitor - defibrillators and cardiology data management systems. CardiacScience also sells a variety of related products and consumables, and providesa comprehensive portfolio of training, maintenance and support services. TheCompany is the successor to various entities that have owned and operatedcardiology-related businesses that sold products under the trusted brand namesBurdick(R), Powerheart(R), and Quinton(R). Cardiac Science is headquartered inBothell, WA, and also has operations in Lake Forest, California; Deerfield,Wisconsin; Shanghai, China and Manchester, United Kingdom.Company Contact: Mike Matysik Cardiac Science Corporation Chief Financial Officer 425-402-2009 Investor Contact: EVC Group, Inc. Douglas Sherk/Jenifer Kirtland 415-896-6820 Media Contact: EVC Group, Inc. Steve DiMattia 646-201-5445

SOURCE Cardiac Science Corporation
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close